期刊文献+

乳腺癌组织中长链非编码RNA-00707的表达及与分子病理分型的相关性

Expression of long-chain non-coding RNA-00707 in breast cancer and its correlation with molecular pathological type
下载PDF
导出
摘要 目的探讨长链非编码RNA-00707(long-chain non-coding RNA-00707,Linc00707)在乳腺癌组织中定性与定量表达,及其与乳腺癌分子病理分型的相关性。方法建立人源脂肪间充质干细胞与人乳腺癌MCF7细胞间接共培养体系,采用LncRNAs芯片技术获得Linc00707,应用RNAscope技术检测136例乳腺癌及癌旁正常乳腺组织中Linc00707的表达;观察mRNA在癌细胞中的表达定位及按照mRNA表达量等级的判读结果,分析Linc00707表达与乳腺癌分子病理分型的相关性。结果136例乳腺癌组织中121例Linc00707阳性,呈细胞核及细胞质内点簇状棕色颗粒分布,乳腺癌及癌旁正常乳腺组织中Linc00707的阳性率分别为89%(121/136)、3.8%(3/78),Linc00707阳性定量评分1分占9.1%(11/121),2分占30.6%(37/121),3分占40.4%(49/121),4分占19.8%(24/121)。Luminal A型、Luminal B型、HER-2过表达型、基底样型乳腺癌中Linc00707的阳性率分别为52.6%(10/19)、98.1%(51/52)、94.9%(37/39)、88.5%(23/26)。Linc00707在乳腺癌组织中的阳性率高于癌旁正常乳腺组织,定量评分高评分(2、3、4分)组的阳性率高于低评分(1分)组,Luminal B型、HER-2过表达型、基底样型乳腺癌中的Linc00707阳性率高于Luminal A型乳腺癌。结论Linc00707可以促进乳腺癌的发生、发展,对乳腺癌的恶性程度评估有一定的临床意义及成为乳腺癌标志物具有潜在应用价值。 Purpose To study the qualitative and quantitative expression of long-chain non-coding RNA-00707(Linc00707)in breast cancer tissues,and to explore its correlation with molecular pathological classification of breast cancer.Methods An indirect co-culture system of human adipose-derived mesenchymal stem cells(HAD-MSCs)and human breast cancer MCF7 cells was established,and Linc00707 was obtained by lncRNAs chip technology.136 breast cancer tissue samples were collected,and the difference of expression of Linc00707 between cancer and adjacent cancer was detected by RNAscope technology.The location of mRNA expression in cancer cells was observed and the results were interpreted according to mRNA expression level,and the correlation between Linc00707 positive expression and pathological molecular subtypes of breast cancer was analyzed by Chi-square test.Results Linc00707 was positive in 121 cases of breast cancer,which was distributed in the nucleus and cytoplasm of cancer cells.The positive expression rates of Linc00707 in breast cancer tissues and adjacent to cancer were 89%(121/136)and 3.8%(3/78),respectively.The positive quantitative score of Linc00707 was 9.1%(11/121)in 1 score,30.6%(37/121)in 2 score,40.4%(49/121)in 3 score and 19.8%(24/121)in 4 score,the positive expression rates of luminal A type,Luminal B type,HER overexpression type and basal type were 52.6%(10/19),98.1%(51/52),94.9%(37/39)and 88.5%(23/26),respectively.The positive expression rate of Linc00707 in breast cancer tissue is higher than that in normal breast tissue adjacent to cancer.Quantitative score analysis shows that the expression rate of high score(2,3 and 4)is higher than that of low score(1),and the positive expression rates of luminal B type,HER overexpression type and basal type are higher than that of luminal A type.Conclusion Linc00707 can promote the occurrence and development of breast cancer.It has a certain clinical significance in evaluating the malignancy of breast cancer and has potential application value as a marker for breast
作者 赵丽华 李静 位嘉 林秋兰 ZHAO Li-hua;LI Jing;WEI Jia;LIN Qiu-lan(Department of Pathology,Civil Aviation General Hospital,Beijing 100123,China;Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100005,China)
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2021年第7期776-779,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 首都临床特色应用研究与临床推广基金(Z171100001017138)。
关键词 乳腺肿瘤 长链非编码RNA 分子病理分型 Linc00707 breast neoplasm long-chain non-coding RNA molecular pathological typing Linc00707
  • 相关文献

参考文献6

二级参考文献35

  • 1Lower EE, Glass E, Blau R, primary and metastatic breast et al. HER-2/neu expression in cancer [ J ]. Breast Cancer Res Treat, 2009,113(2) :301-306. 被引量:1
  • 2Wang F, Flanagan J, Su N, et al. RNAscope:a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues [Jl. J Mol Diagn, 2012,14( 1 ) :22-29. 被引量:1
  • 3Park S, Wang HY, Kim S, et al. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues [ J ]. Int J Clin Exp Pathol, 2014,7 (10) : 6752-6759. 被引量:1
  • 4Mar N, Vredenburgh JJ, Wasser JS. Targeting HER2 in the treatment of non-small cell lung cancer[J]. Lung Cancer, 2015, 87 (3) :220-225. 被引量:1
  • 5Belgrader P, Tanner SC, Regan JF, et al. Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue [ J ]. Clinical Chemistry, 2013,59(6) : 991-994. 被引量:1
  • 6Paik S, Kim C, Wolmark N. HER2 status and benefit from adjuvant trastuzumab in breast cancer[ J]. N Engl J Med,2008, 358 : 1409-1411. 被引量:1
  • 7Colditz G A, Bohlke K. Priorities for the primary prevention of breast cancer[J]. CA Cancer J Clin, 2014,64(3) :186 -94. 被引量:1
  • 8Perou C M, Sorlie T, Eisen M B, et at. Molecular portraits of hu?man breast tumors [J]. Nature, 2000,406 (6797) : 747 - 52. 被引量:1
  • 9Leong S P, Shen Z Z, Liu T J, et at. Is breast cancer the same disease in Asian and Western countries [J] ? World J Surg, 2010, 34(10):2308-14. 被引量:1
  • 10Carey LA, Perou C M, Livasy C A, et at. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J] . JAMA, 2006,295(21) :2492 -502. 被引量:1

共引文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部